USATF Partners With BD To Provide Rapid COVID-19 Testing To Enhance Athlete Safety At Track & Field Events
"Providing USATF athletes a safe place to compete is always our top priority but during a pandemic, we needed to find a partner that could provide rapid COVID-19 testing expertise in order to give our athletes peace of mind as they focus on competing," said USATF CEO
BD Veritor™ Plus is a portable, rapid and easy-to-use point-of-care antigen test that detects SARS-CoV-2 – the novel coronavirus that causes COVID-19 – with a simple, digital display. By providing results in just 15 minutes, this test will help ensure the safety of our country's fastest and strongest track and field athletes, their coaches, event organizers and other personnel.
"BD is committed to helping people around the world get back on track with their normal lives as soon as possible, which includes providing a safe environment for athletic competitions," said
Testing to Keep the Athletes Safe
As the official COVID-19 testing partner of USATF, tests using the BD Veritor™ Plus System will be conducted at multiple events throughout the Journey to Gold – Tokyo Outdoor Track &
The USATF COVID-19 safety plan exceeds all
BD's partnership with USATF is part of the company's overarching commitment to helping get people back to their normal lives as soon as possible. Ensuring people have a fast and reliable way to determine their COVID-19 status is critical to slowing the spread of the disease while helping people return to the activities they've been missing.
USATF is also committed to protecting the welfare of its constituents, fans and stakeholders during this unprecedented time.
Through the first two Journey to Gold meets, 410 COVID-19 tests have already been administered, with two positive results. Thousands of additional tests will be administered, delivering on USATF and BD's commitment to athlete and community safety.
Fans can follow along with #JourneyToGold, #TrackFieldTrials20 and #USATF on Twitter, Instagram,
About USATF
About BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2
The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay has not been cleared or approved by the
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts: |
|
Media: |
Investors: |
|
|
VP, Public Relations |
SVP, Strategy & Investor Relations |
858.617.2361 |
201.847.5378 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/usatf-partners-with-bd-to-provide-rapid-covid-19-testing-to-enhance-athlete-safety-at-track--field-events-301275635.html
SOURCE BD (